These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4159736)

  • 1. Tyramine and amphetamine.
    Eble JN; Rudzik AD
    Lancet; 1966 Apr; 1(7440):766. PubMed ID: 4159736
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural activity relationships of a series of amines injected before and after monoamine oxidase inhibitor.
    Gatgounis J
    Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):412-20. PubMed ID: 5838346
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of 3 H-norepinephrine released from the adrenergic neuron.
    Leitz FH; Stefano FJ
    J Pharmacol Exp Ther; 1971 Sep; 178(3):464-73. PubMed ID: 4105925
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 5. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on monoamine oxidase inhibitors. I. Mode of action of hydrazine derivatives and alpha-methyl-phenethylamine].
    TAKAGI K; GOMI Y
    Yakugaku Zasshi; 1962 Oct; 82():1431-4. PubMed ID: 13980260
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypertension induced in dogs by tyramine and nicotine and plasma levels of catecholamines].
    Beauvallet M; Fugazza J; Godefroy F; Solier M
    J Physiol (Paris); 1967; 59(4 Suppl):343-4. PubMed ID: 5608715
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible functional differentiation between the stores from which adrenergic nerve stimulation, tyramine and amphetamine release noradrenaline.
    Obianwu HO
    Acta Physiol Scand; 1969; 75(1):92-101. PubMed ID: 5785154
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol.
    Abrams JH; Schulman P; White WB
    N Engl J Med; 1985 Jul; 313(1):52. PubMed ID: 4000229
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of intraneuronal monoamine oxidase on the sympathomimetic response to amphetamine.
    Obianwu HO
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):69. PubMed ID: 5314439
    [No Abstract]   [Full Text] [Related]  

  • 13. D-amphetamine and DL-alpha-N-methyltryptamine eliminate the irreversible inhibition of mitochondrial monoamine oxidase, caused by clorgyline. The specific action on the tyramine oxidation.
    Severina IS
    Biochem Int; 1984 Aug; 9(2):219-28. PubMed ID: 6487343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of monoamine oxidase types A and B by d- and l-amphetamine.
    Miller HH; Clarke DE
    Commun Psychopharmacol; 1978; 2(4):319-25. PubMed ID: 729356
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the blood pressure effects of reserpine in dogs pretreated with amphetamine or tyramine.
    Yelnosky J; McGill JS; Mastrangelo AS
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):416-23. PubMed ID: 5916744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monoamine oxidase inhibition and hypertensive paroxysms: importance of the method of administration].
    Sicuteri F; Del Bianco PL; Del Bene E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(17):1163-6. PubMed ID: 5971368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase inhibitors and low alcohol or alcohol free drinks.
    Beswick DT; Rogers ML
    BMJ; 1990 Jul; 301(6744):179-80. PubMed ID: 2390609
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
    Bieck PR
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyramine in alcohol-free beer.
    Murray JA; Walker JF; Doyle JS
    Lancet; 1988 May; 1(8595):1167-8. PubMed ID: 2896988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.